TrianglePUBLICATIONS · 17938252
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2008 Jan 1
- First author
- Schulz H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Schulz H
- type
- Author
- name
- Rehwald U
- type
- Author
- name
- Morschhauser F
- type
- Author
- name
- Elter T
- type
- Author
- name
- Driessen C
- type
- Author
- name
- Rüdiger T
- type
- Author
- name
- Borchmann P
- type
- Author
- name
- Schnell R
- type
- Author
- name
- Diehl V
- type
- Author
- name
- Engert A
- type
- Author
- name
- Reiser M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Schulz H
- type
- Author
- name
- Rehwald U
- type
- Author
- name
- Morschhauser F
- type
- Author
- name
- Elter T
- type
- Author
- name
- Driessen C
- type
- Author
- name
- Rüdiger T
- type
- Author
- name
- Borchmann P
- type
- Author
- name
- Schnell R
- type
- Author
- name
- Diehl V
- type
- Author
- name
- Engert A
- type
- Author
- name
- Reiser M
- type
- Author
- bibliography ids
- nci-bib-d69ee476a833d025c1250265
- book metadata
- content sha256
- c9fd7a4db417a82f1d73a4fd28f22e033f16ab65e8432cef28ea6d9d2a6911ae
- document type
- citation
- dois
- 10.1182/blood-2007-03-078725
- electronic publication date
- display
- 2007 Oct 15
- precision
- day
- year
- 2007
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:17938252
- immutable id
- pubmed:17938252@c9fd7a4db417a82f1d73a4fd28f22e033f16ab65e8432cef28ea6d9d2a6911ae
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 1
- name
- Blood
- nlm unique id
- 7603509
- pages
- 109-11
- volume
- 111
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 17938252
- provenance
- batch id
- 89a0f2206e11ca092d02
- provider
- NCBI PubMed ESummary
- record sha256
- 83ab2ea64a15808e06279c484e522e1aa919d0a5007a9bbed1a46a254b22fb98
- response sha256
- 7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
- retrieved at
- 2026-09-09T23:46:16.784581+00:00
- publication date
- display
- 2008 Jan 1
- precision
- day
- year
- 2008
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).
Preserved source evidence · Not medical advice